Actively Recruiting
Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System
Led by Christopher P Kellner · Updated on 2025-10-28
250
Participants Needed
1
Research Sites
300 weeks
Total Duration
On this page
Sponsors
C
Christopher P Kellner
Lead Sponsor
I
IRRAS
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study is a multi-center prospective cohort, controlled, phase 4 post-market registry evaluating the efficacy and radiographic outcomes associated with the use of the IRRAflow® Active Fluid Exchange System compared to standard of care external ventricular drains.
CONDITIONS
Official Title
Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3E=18 years of age
- Intracranial hemorrhage documented on head CT or MRI scan
- Indication for active fluid exchange evaluated by treating physician
- Signed informed consent obtained by patient or Legal Authorized Representative
- Scheduled enrollment and treatment within 72 hours of last known well (LKW)
You will not qualify if you...
- Glasgow Coma Scale (GCS) �3C= 5
- Pregnancy
- Fixed and dilated pupil
- Life-threatening medical condition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
S
Sukaina Davdani
CONTACT
S
Sydney Edwards
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here